292 related articles for article (PubMed ID: 38544830)
1. Animal model considerations for chordoma research: reproducing the tumor microenvironment
Campilan B; Schroeder C; Sagaityte E; Arditi J; Leary OP; Gokaslan ZL; Sullivan PLZ; Martinez-Moreno M
Front Oncol; 2024; 14():1330254. PubMed ID: 38544830
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
3. Potential Perturbations of Critical Cancer-regulatory Genes in Triple-Negative Breast Cancer Cells Within the Humanized Microenvironment of Patient-derived Xenograft Models.
Her Y; Yun J; Son HY; Heo W; Kim JI; Moon HG
J Breast Cancer; 2024 Feb; 27(1):37-53. PubMed ID: 38233337
[TBL] [Abstract][Full Text] [Related]
4. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies.
Xu J; Shi Q; Wang B; Ji T; Guo W; Ren T; Tang X
Front Immunol; 2023; 14():1257254. PubMed ID: 37720221
[TBL] [Abstract][Full Text] [Related]
6. Large-cohort humanized NPI mice reconstituted with CD34
Xu X; Gu H; Li H; Gao S; Shi X; Shen J; Li B; Wang H; Zheng K; Shao Z; Cheng P; Cha Z; Peng S; Nie Y; Li Z; Guo S; Qian B; Jin G
FASEB J; 2022 Apr; 36(4):e22244. PubMed ID: 35262964
[TBL] [Abstract][Full Text] [Related]
7. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
[TBL] [Abstract][Full Text] [Related]
8. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
9. The humanized mouse: Emerging translational potential.
Morton JJ; Alzofon N; Jimeno A
Mol Carcinog; 2020 Jul; 59(7):830-838. PubMed ID: 32275343
[TBL] [Abstract][Full Text] [Related]
10. Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies.
Sanmamed MF; Chester C; Melero I; Kohrt H
Ann Oncol; 2016 Jul; 27(7):1190-8. PubMed ID: 26912558
[TBL] [Abstract][Full Text] [Related]
11. Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
Lang J; Capasso A; Jordan KR; French JD; Kar A; Bagby SM; Barbee J; Yacob BW; Head LS; Tompkins KD; Freed BM; Somerset H; Clark TJ; Pitts TM; Messersmith WA; Eckhardt SG; Wierman ME; Leong S; Kiseljak-Vassiliades K
J Clin Endocrinol Metab; 2020 Jan; 105(1):26-42. PubMed ID: 31513709
[TBL] [Abstract][Full Text] [Related]
12. Autologously Humanized Mice for Immune-Oncologic Studies.
Fu J; Kim YJ
Curr Protoc Pharmacol; 2020 Jun; 89(1):e76. PubMed ID: 32469451
[TBL] [Abstract][Full Text] [Related]
13. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
14. Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression.
Xu J; Shi Q; Lou J; Wang B; Wang W; Niu J; Guo L; Chen C; Yu Y; Huang Y; Guo W; Lan J; Zhu Y; Ren T; Tang X
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37185233
[TBL] [Abstract][Full Text] [Related]
15. Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.
Lopez DC; Robbins YL; Kowalczyk JT; Lassoued W; Gulley JL; Miettinen MM; Gallia GL; Allen CT; Hodge JW; London NR
Front Oncol; 2022; 12():1012058. PubMed ID: 36338744
[TBL] [Abstract][Full Text] [Related]
16. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
[TBL] [Abstract][Full Text] [Related]
17. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment.
Meng Y; Liu H; Zhu H; Zhang W; Sun D; Han X; Liu Y; Luo G
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212125
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice.
Chen A; Neuwirth I; Herndler-Brandstetter D
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296949
[TBL] [Abstract][Full Text] [Related]
19. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model.
Zhao Y; Wang J; Liu WN; Fong SY; Shuen TWH; Liu M; Harden S; Tan SY; Cheng JY; Tan WWS; Chan JKY; Chee CE; Lee GH; Toh HC; Lim SG; Wan Y; Chen Q
Hepatology; 2021 Sep; 74(3):1395-1410. PubMed ID: 33738839
[TBL] [Abstract][Full Text] [Related]
20. Humanized Mouse Models for Immuno-oncology Drug Discovery.
Kumari R; Feuer G; Bourré L
Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
